Identification de cibles

Validation de cibles

Identification de « Hits »

Transition de « Hits » à têtes de séries

Optimisation de têtes de série

Études pré-cliniques

Études cliniques

PROJETS EN INCUBATION
PROJETS EN MATURATION
  • Undisclosed Project 2
  • Novel ILK modulators *
  • Small molecule inhibitors of the MAP kinases signaling pathway
  • Novel fragments in AML resistance *
  • HDACs as antifungals *
  • Human Telomerase Inhibitors *
  • Undisclosed Project 4
  • Undisclosed Project 3
  • Plk1-specific inhibitors *
  • Inhibition of GPCR in brain tumors *
  • Undisclosed Project 5
  • Pharmacological Chaperones *
  • Chemogenomics in AML *
  • Ribavirin in Leukemia
  • Stem Cell expansion & Transplantation (Small molecules) *
  • Undisclosed Project 6

Pour plus d’information sur nos programmes,
Consultez ce document

 
Technologies en support à la découverte de médicaments
  • Engineered Kinases
  • CRISPR/Cas9 chemogenomic profiling
  • BRET Biosensor Program
  • Cyclic peptidomimetics
  • Proprietary Small Molecules (IRIC’s collection)
  • SUMOylation Detection Method

Légende

  *    Project for potential partnership
  IRICoR investment at later stage (Maturation Project Committee)
  IRICoR investment at early stage (Incubation Project Committee)
  IRICoR investment at both early and late stages of development

Dernière mise à jour: 25-08-2017